title: [Intrathecal distribution of ACNU by various modes of its administration analyzed by HPLC and autoradiography].
abstract: Various modes of administration of ACNU (nimustine hydrochloride) were tried to make clear which mode is the best method to obtain intrathecal diffuse distribution of ACNU to match the condition of killing of glioma cells (10 micrograms/ml; greater than 30 min.). Tried modes of administration included 1)bolus injection into ventricular cavity, 2)bolus injection into cisterna magna, 3)bolus injection into lumbar subarachnoid space, 4)ventriculo-lumbar perfusion, 5)chiasmatic cistern-lumbar perfusion. Used dose of ACNU was 5 mg/body for all modes of administration. ACNU level in CSF was measured by HPLC method specially developed by authors. To make clear intrathecal distribution of ACNU, autoradiography using 14C-ethylene-ACNU was studied after administration of 10 muCi/Kg of radioactive ACNU. The images were studied by image analyzer system (BAS-2,000 system developed by Fuji Film Co. Ltd). Among the modes of administration tried, ventriculo-lumbar perfusion method gave the best results in terms of lumbar, ventricular, cisterna magna, and basal cistern distribution of ACNU to match the cell kill condition experimentally ascertained. Although, bolus injection of ACNU into cisterna magna gave sufficient amount of ACNU in lumbar region, the initial level of ACNU was too high in cisterna magna, and administration of ACNU once a week for three times in a canine cisterna magna resulted in considerable deterioration of brain stem and basal structure. In addition to it, the level of ACNU in ventricular cavity was not detectable. Lumbar bolus injection resulted in also too much ACNU accumulation at the injected lumbar area, and at the cisterna magna region, ACNU was not detectable.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Division of Neurosurgery, Tottrori University School of Medicine, Yonago, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Hori
authors.forename: J
authors.initials: J
authors.lastname: Hirao
authors.forename: H
authors.initials: H
authors.lastname: Okamoto
authors.forename: M
authors.initials: M
authors.lastname: Nishiyama
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
authors.forename: K
authors.initials: K
authors.lastname: Muraoka
authors.forename: F
authors.initials: F
authors.lastname: Tabuchi
authors.forename: T
authors.initials: T
authors.lastname: Tatsuhara
authors.forename: E
authors.initials: E
authors.lastname: Nakajima
mesh_terms: D000818:Animals; D001345:Autoradiography; D001932:Brain Neoplasms / Q000378:metabolism* / Q000473:pathology; D002851:Chromatography, High Pressure Liquid; D002946:Cisterna Magna; D004285:Dogs; D005910:Glioma / Q000378:metabolism* / Q000473:pathology; D007276:Injections, Intraventricular; D007278:Injections, Spinal; D015376:Nimustine / Q000493:pharmacokinetics*; D010477:Perfusion
chemical_list: D015376:Nimustine